ZA907930B - Pressing having sustained release of active compound - Google Patents

Pressing having sustained release of active compound

Info

Publication number
ZA907930B
ZA907930B ZA907930A ZA907930A ZA907930B ZA 907930 B ZA907930 B ZA 907930B ZA 907930 A ZA907930 A ZA 907930A ZA 907930 A ZA907930 A ZA 907930A ZA 907930 B ZA907930 B ZA 907930B
Authority
ZA
South Africa
Prior art keywords
pressing
active compound
sustained release
sustained
release
Prior art date
Application number
ZA907930A
Other languages
English (en)
Inventor
Brigitta Korsatko-Wabnegg
Korsatko-Wabnegg Brigitta
Werner Korsatko
Korsatko Werner
Original Assignee
Biotechnolog Forschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnolog Forschung Gmbh filed Critical Biotechnolog Forschung Gmbh
Publication of ZA907930B publication Critical patent/ZA907930B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
ZA907930A 1989-10-16 1990-10-04 Pressing having sustained release of active compound ZA907930B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT236789 1989-10-16

Publications (1)

Publication Number Publication Date
ZA907930B true ZA907930B (en) 1991-08-28

Family

ID=3533052

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907930A ZA907930B (en) 1989-10-16 1990-10-04 Pressing having sustained release of active compound

Country Status (8)

Country Link
US (1) US5128144A (ja)
EP (1) EP0423484B1 (ja)
JP (1) JPH03133922A (ja)
KR (1) KR910007516A (ja)
AU (1) AU632370B2 (ja)
CA (1) CA2025453A1 (ja)
DE (1) DE59003337D1 (ja)
ZA (1) ZA907930B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE216262T1 (de) * 1991-02-01 2002-05-15 Massachusetts Inst Technology Biologisch abbaubare polymermischungen zur arzneistoffabgabe
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6867248B1 (en) 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6828357B1 (en) 1997-07-31 2004-12-07 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
ES2281147T3 (es) * 1997-12-22 2007-09-16 Metabolix, Inc. Composiciones de polihidroxialcanoato con tasas controladas de degradacion.
EP1159015A1 (en) 1999-03-04 2001-12-05 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
EP2305324B1 (en) * 1999-03-25 2014-09-17 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6608170B1 (en) * 1999-03-31 2003-08-19 Cornell Research Foundation, Inc. Syndiotactic poly(lactic acid)
EP1267841B1 (en) * 2000-03-31 2004-11-24 Nycomed Austria GmbH Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
EA200201044A1 (ru) 2000-03-31 2003-04-24 Нюкомед Аустриа Гмбх Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин
EP1282406A1 (en) * 2000-03-31 2003-02-12 Nycomed Austria GmbH Pharmaceutical kit comprising midodrine as an active drug substance
US6761904B2 (en) * 2000-03-31 2004-07-13 Nycomed Austria Gmbh Pharmaceutical kit comprising midodrine as active drug substance
PT1638615E (pt) 2003-05-08 2015-02-04 Tepha Inc Fibras e tecidos médicos de polihidroxialcanoato
ES2395077T3 (es) * 2003-07-08 2013-02-08 Tepha, Inc. Matrices poli-4-hidroxibutirato para una administración prolongada de medicamentos
WO2005020825A1 (en) * 2003-08-22 2005-03-10 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
WO2006015276A2 (en) * 2004-08-03 2006-02-09 Tepha, Inc. Non-curling polyhydroxyalkanoate sutures
ES2362221T3 (es) * 2005-01-28 2011-06-29 Tepha, Inc. Embolización con partículas poli-4-hidroxibutirato.
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
JP2009245846A (ja) * 2008-03-31 2009-10-22 Suzhou Marsleds Optoelectronics Co Ltd Ｌｅｄ街路灯
EP3045043B1 (en) 2009-02-26 2020-04-29 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US11202760B2 (en) 2016-09-30 2021-12-21 Xenamed Corp. Compositions of midodrine and methods of using the same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
DE2856901D2 (de) * 1977-06-07 1980-11-13 Garching Instrumente Form of implant medicament and preparation process
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3378250D1 (en) * 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
AT382076B (de) * 1982-10-15 1987-01-12 Chemie Linz Ag Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3343551A1 (de) * 1983-12-01 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur biotechnologischen herstellung von poly-d(-)-3-hydroxybuttersaeure
DE3410380A1 (de) * 1984-03-21 1985-10-10 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen
DE3417576A1 (de) * 1984-05-11 1985-11-14 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung
AT383270B (de) * 1984-05-15 1987-06-10 Chemie Linz Ag Verfahren zur herstellung von oralen retardformen des alpha-(2,5-dimethoxy-phenyl)-betaglycinamido|thanols
NL8401912A (nl) * 1984-06-15 1986-01-02 Tno Met aktieve stof beladen biodegradeerbare polymeersubstraten, geschikt voor het gecontroleerd afgeven van de aktieve stof door middel van een membraan.
DE3430131A1 (de) * 1984-08-16 1986-02-27 Heidelberger Druckmaschinen Ag, 6900 Heidelberg Bogenuebertragungszylinder in bogenrotationsdruckmaschinen
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
DE3712095A1 (de) * 1987-04-10 1988-10-20 Lentia Gmbh Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe
JPH0613602B2 (ja) * 1987-07-14 1994-02-23 三井東圧化学株式会社 ｄ▲ｌ▼−乳酸−グリコール酸共重合物の製造方法
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
DE3738228A1 (de) * 1987-11-11 1989-05-24 Hoechst Ag Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
AU2377288A (en) * 1987-11-27 1989-07-13 Ici Australia Operations Proprietary Limited Livestock treatment

Also Published As

Publication number Publication date
AU6379690A (en) 1991-04-18
AU632370B2 (en) 1992-12-24
CA2025453A1 (en) 1991-04-17
KR910007516A (ko) 1991-05-30
US5128144A (en) 1992-07-07
EP0423484B1 (de) 1993-11-03
DE59003337D1 (de) 1993-12-09
JPH03133922A (ja) 1991-06-07
EP0423484A1 (de) 1991-04-24

Similar Documents

Publication Publication Date Title
ZA907930B (en) Pressing having sustained release of active compound
GB8403138D0 (en) Sustained release of active ingredient
NZ225101A (en) Sustained release composition
AU639947B2 (en) Sustained release elements
AU1174388A (en) Sustained release dosage forms
EP0510200A4 (en) Structure of release part
ZA906955B (en) Stable solutions of mitomycin c
EP0405560A3 (en) Preparation of tertiary-hydrocarbylsilyl compounds
AU7942087A (en) Sustained release formulations
ZA9010216B (en) Pharmaceutically active oxazole compounds
ZA908278B (en) Fungicidal combinations of active compounds
GB8916391D0 (en) Preparation of polyacetals
GB2237839B (en) Powered release of connectors
ZA9010218B (en) Pharmaceutically active normanyl compounds
GB8928832D0 (en) Active compounds
GB8928833D0 (en) Active compounds
GB8928836D0 (en) Active compounds
GB8928830D0 (en) Active compounds
GB8909200D0 (en) Active compounds
GB8912349D0 (en) Active compounds
GB8928834D0 (en) Active compounds
GB8928835D0 (en) Active compounds
GB8912348D0 (en) Active compounds
GB8928831D0 (en) Active compounds
AU663388B2 (en) Sustained release formulations